Natalie Hughes | |
---|---|
Academic background | |
Alma mater | University of Otago , University of Otago |
Academic work | |
Institutions | University of Otago , University of Kansas |
Doctoral students | Rhiannon Braund,Vanda Symon |
Natalie June Hughes,also known as Natalie Medlicott and Natalie Hughes-Medlicott,is a New Zealand pharmaceutical scientist,and is a full professor at the University of Otago.
Hughes gained a Bachelor of Pharmacy at the University of Otago,and worked as a clinical tutor at the university and at Dunedin Hospital while completing her PhD. Her doctoral thesis was titled Controlled delivery of Chlorhexidine for the treatment of periodontal diseases at the University of Otago. [1] [2] After postdoctoral research at the University of Kansas,where she researched anti-cancer drugs,Hughes returned to New Zealand to join the faculty of the University of Otago,rising to full professor in 2022. [3] [4] [2] She is head of clinical pharmacy and associate dean of undergraduate studies,and was deputy dean. [2]
Hughes's research covers pharmaceutical formulation and drug delivery. Hughes and her students have researched delivery of drugs to neonates,the use of ketamine for treatment-resistant anxiety,treatment for wound-healing in dentistry,and the formulation of a saliva replacement for dry-mouth conditions. [5] [3] [6] She has also commented in the media on controversial changes to publicly-funded epilepsy drugs. [7]
Hughes's research on a new treatment for severe pain was awarded the University of Otago's 2017 translational research grant,allowing Hughes and collaborators Paul Glue and Ailsa McGregor to trial the treatment in human patients. [8]
Hughes was awarded the Best Collaboration Award in the 2019 Health Research Excellence Awards. The award was made for a collaboration between Hughes,Lisa Kremer,David Reith,Roland Broadbent,Liza Edmonds,Frances McCaffrey and Mary–Jane Sime,on a controlled trial on drug administration to neonates. [9] [10]
A suppository is a dosage form used to deliver medications by insertion into a body orifice, where it dissolves or melts to exert local or systemic effects. There are three types of suppositories, each to insert into a different sections: rectal suppositories into the rectum, vaginal suppositories into the vagina, and urethral suppositories into the urethra of a male.
Iontophoresis is a process of transdermal drug delivery by use of a voltage gradient on the skin. Molecules are transported across the stratum corneum by electrophoresis and electroosmosis and the electric field can also increase the permeability of the skin. These phenomena, directly and indirectly, constitute active transport of matter due to an applied electric current. The transport is measured in units of chemical flux, commonly μmol/(cm2*hour). Iontophoresis has experimental, therapeutic and diagnostic applications.
The miswak is a teeth-cleaning twig made from the Salvadora persica tree. The miswak's properties have been described thus: "Apart from their antibacterial activity which may help control the formation and activity of dental plaque, they can be used effectively as a natural toothbrush for teeth cleaning. Such sticks are effective, inexpensive, common, available, and contain many medical properties".
Drug delivery refers to approaches, formulations, manufacturing techniques, storage systems, and technologies involved in transporting a pharmaceutical compound to its target site to achieve a desired therapeutic effect. Principles related to drug preparation, route of administration, site-specific targeting, metabolism, and toxicity are used to optimize efficacy and safety, and to improve patient convenience and compliance. Drug delivery is aimed at altering a drug's pharmacokinetics and specificity by formulating it with different excipients, drug carriers, and medical devices. There is additional emphasis on increasing the bioavailability and duration of action of a drug to improve therapeutic outcomes. Some research has also been focused on improving safety for the person administering the medication. For example, several types of microneedle patches have been developed for administering vaccines and other medications to reduce the risk of needlestick injury.
Magnetofection is a transfection method that uses magnetic fields to concentrate particles containing vectors to target cells in the body. Magnetofection has been adapted to a variety of vectors, including nucleic acids, non-viral transfection systems, and viruses. This method offers advantages such as high transfection efficiency and biocompatibility which are balanced with limitations.
Esketamine, also known as (S)-ketamine or S(+)-ketamine, is the S(+) enantiomer of ketamine. It is a dissociative hallucinogen drug used as a general anesthetic and as an antidepressant for treatment of depression. It is sold under the brand names Spravato, Ketanest, among others. Esketamine is the active enantiomer of ketamine in terms of NMDA receptor antagonism and is more potent than racemic ketamine.
Nasal administration, popularly known as snorting, is a route of administration in which drugs are insufflated through the nose. It can be a form of either topical administration or systemic administration, as the drugs thus locally delivered can go on to have either purely local or systemic effects ibuprofen or Tylenol for headaches along with pains such as severe toothaches. Nasal sprays are locally acting drugs such as decongestants for cold and allergy treatment, whose systemic effects are usually minimal. Examples of systemically active drugs available as nasal sprays are migraine drugs, rescue medications for overdose and seizure emergencies, nicotine replacement, and hormone treatments.
Sankaran "Thai" Thayumanavan is an Indian-American chemist, who is currently a Distinguished Professor of Chemistry at the University of Massachusetts Amherst. He is known for his work in polymer chemistry. He is a Fellow of the American Association for the Advancement of Science (AAAS).
Rhiannon Braund is a New Zealand academic and registered pharmacist. She is a professor in the Department of Preventive and Social Medicine at the University of Otago.
Helen M. Burt is a British-Canadian pharmaceutical scientist who is the Angiotech Professor of Drug Delivery at the University of British Columbia. She serves as Associate Vice President of Research and Innovation at UBC. Her research considers novel therapeutics based on nanotechnology, including drug delivery systems for the treatment of bladder cancer and coronary artery disease.
Topical cream formulation is an emulsion semisolid dosage form that is used for skin external application. Most of the topical cream formulations contain more than 20 per cent of water and volatiles and/or less than 50 per cent of hydrocarbons, waxes, or polyethylene glycols as the vehicle for external skin application. In a topical cream formulation, ingredients are dissolved or dispersed in either a water-in-oil (W/O) emulsion or an oil-in-water (O/W) emulsion. The topical cream formulation has a higher content of oily substance than gel, but a lower content of oily ingredient than ointment. Therefore, the viscosity of topical cream formulation lies between gel and ointment. The pharmacological effect of the topical cream formulation is confined to the skin surface or within the skin. Topical cream formulation penetrates through the skin by transcellular route, intercellular route, or trans-appendageal route. Topical cream formulation is used for a wide range of diseases and conditions, including atopic dermatitis (eczema), psoriasis, skin infection, acne, and wart. Excipients found in a topical cream formulation include thickeners, emulsifying agents, preservatives, antioxidants, and buffer agents. Steps required to manufacture a topical cream formulation include excipient dissolution, phase mixing, introduction of active substances, and homogenization of the product mixture.
Anne-Marie Caminade is a French chemist who is Director of Research Exceptional Class at the French National Centre for Scientific Research. Her research considers dendrimers and heterochemistry. She was awarded the 2021 Société chimique de France Achille le Bel Grand Prize.
Vitaliy Khutoryanskiy FRSC is a British and Kazakhstani scientist, a Professor of Formulation Science and a Royal Society Industry Fellow at the University of Reading. His research focuses on polymers, biomaterials, nanomaterials, drug delivery, and pharmaceutical sciences. Khutoryanskiy has published over 200 original research articles, book chapters, and reviews. His publications have attracted > 11000 citations and his current h-index is 50. He received several prestigious awards in recognition for his research in polymers, colloids and drug delivery as well as for contributions to research peer-review and mentoring of early career researchers. He holds several honorary professorship titles from different universities.
Susan Reutzel-Edens is an American chemist who is the Head of Science at the Cambridge Crystallographic Data Centre. Her work considers solid state chemistry and pharmaceuticals. She is interested in crystal structure predictions. She serves on the editorial boards of CrystEngComm and Crystal Growth & Design.
Ketamine-assisted psychotherapy(KAP) is the use of prescribed doses of ketamine, the drug, as an adjunct to psychotherapy sessions. KAP shows significant potential in treating mental disorders such as treatment-resistant depression (TRD), anxiety, obsessive–compulsive disorders (OCD), post-traumatic stress disorders (PTSD), and other conditions. It can also be used for those experiencing substance abuse and physical pain. While it is primarily used as a veterinary anaesthetic, ketamine has also been found to have rapid analgesic and hallucinogenic effects, which has sparked interest in its use as an antidepressant. Despite initial trials of its use in the treatment of mental disorders focussing primarily on its antidepressant effects, newer studies are attempting to harness its psychedelic effects to bring about altered states of consciousness, which will augment the adjunct psychotherapy. Ketamine's neuroplasticity-promoting effects strengthen the cognitive restructuring that takes place through traditional psychotherapy, thereby leading to long-lasting behavioural change. KAP offers promising directions for research on new antidepressant alternatives, but is still not sufficiently defined or evaluated as a treatment combination.
Penetration enhancers are chemical compounds that can facilitate the penetration of active pharmaceutical ingredients (API) into or through the poorly permeable biological membranes. These compounds are used in some pharmaceutical formulations to enhance the penetration of APIs in transdermal drug delivery and transmucosal drug delivery. They typically penetrate into the biological membranes and reversibly decrease their barrier properties.
An invasome are a type of artificial vesicle nanocarrier that transport substances through the skin, the most superficial biological barrier. Vesicles are small particles surrounded by a lipid layer that can carry substances into and out of the cell. Artificial vesicles can be engineered to deliver drugs within the cell, with specific applications within transdermal drug delivery. However, the skin proves to be a barrier to effective penetration and delivery of drug therapies. Thus, invasomes are a new generation of vesicle with added structural components to assist with skin penetration.
Cervical drug delivery is a route of carrying drugs into the body through the vagina and cervix. This is a form of localized drug delivery that prevents the drugs from impacting unintended areas of the body, which can lower side effects of toxic drugs such as chemotherapeutics. Cervical drug delivery has specific applications for a variety of female health issues: treatment of cervical cancer, pregnancy prevention, STD prevention, and STD treatment.
Miqin Zhang is an American materials scientist who is the Kyocera Professor of Materials Science at the University of Washington. Her research considers the development of new biomaterials for medical applications. Her group develops nanoparticles for cancer diagnosis and imaging, biocompatible materials for drug delivery and cell-based biosensors.
Artificial intelligence in pharmacy is the application of artificial intelligence (AI) to the discovery, development, and the treatment of patients with medications. AI in pharmacy practices has the potential to revolutionize all aspects of pharmaceutical research as well as to improve the clinical application of pharmaceuticals to prevent, treat, or cure disease. AI, a technology that enables machines to simulate human intelligence, has found applications in pharmaceutical research, drug manufacturing, drug delivery systems, clinical trial optimisation, treatment plans, and patient-centered services.